biontech.de (BNTX): Rentabilitas operasi

Logo korporat perusahaan BioNTech SE (BNTX)

The decline in COVID-19 vaccine revenues has impacted the price action of BioNTech SE (BNTX), where the indicator level stands at -61.20. The operating profit margin demonstrates a dependency on the success of the oncology pipeline and R&D expenditures. Cash flow instability, driven by a limited number of commercial products, complicates forecasting; consequently, BioNTech SE (BNTX) relies on extensive reserves and strategic partnerships to advance medical development.

BNTX - Rasio bathi operasi biontech.de ing rentang 04.07.2022 - 19.11.2026

Rincian analitis perusahaan BioNTech SE

- rega lan prakiraan konsensus rega:
Pambiji fundamental perusahaan:BioNTech Group
Produk dadi BioNTech Pharma

To identify fundamental sector leaders, the analyst evaluates the business's ability to convert revenue into operating income before taxes and interest payments. This metric measures the efficiency of production cost management, which is critical for BioNTech SE (BNTX) when scaling oncology vaccines through a network of external contractors, reflecting the model's resilience to vendor changes via the core operating profit margin.

Analisis pesaing BioNTech SE

ARGX (argenx N.V.) - Margin operasi|ABIVAX (ABVX) - Rentabilitas kegiatan operasi|Margin operasi ADMA|Rasio bathi operasi PTGX|Rentabilitas operasi Immunovant Corp IMVT|Margin operasi Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Rentabilitas operasi|Rentabilitas kegiatan operasi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Margin dodolan operasi|Aurinia Pharmaceuticals Inc. (AUPH) - Margin operasi|Margin dodolan operasi BCRX|Rentabilitas dodolan operasi Vera Therapeutics Inc VERA|Margin dodolan operasi DNTH (Dianthus Pharma)|Rentabilitas kegiatan operasi Pharvaris N.V.|AbCellera Biologics Inc - Margin dodolan operasi|Tourmaline Bio (TRML) - Rentabilitas dodolan operasi|PGEN - Rentabilitas operasi|Tingkat bathi operasi PHAR (Pharming Group NV)|NKTR: Margin operasi|Upstream Bio Corp - Tingkat bathi operasi|Rentabilitas operasi Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Rentabilitas kegiatan operasi|Margin operasi GOSS|Margin dodolan operasi KalVista Pharmaceuticals, Inc. KALV|Rentabilitas operasi Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Rentabilitas dodolan operasi|SVRA - Rentabilitas operasi|Rigel Pharmaceuticals - Rasio bathi operasi|AnaptysBio Corp (ANAB) - Rentabilitas operasi|ATXS - Rentabilitas kegiatan operasi|Rentabilitas operasi enGene Holdings Inc.|RAPT: Tingkat bathi operasi|Margin operasi JBIO|Margin dodolan operasi aclaristx.com ACRS|Rentabilitas operasi Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Rentabilitas dodolan operasi|Cabaletta Bio, Inc - Margin operasi|Rentabilitas dodolan operasi Ventyx Biosciences|THTX (theratech.com) - Margin dodolan operasi|Margin dodolan operasi Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Margin operasi|Rentabilitas dodolan operasi Agenus Inc. AGEN|Margin dodolan operasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Tingkat bathi operasi|Rentabilitas operasi atyrpharma.com ATYR|Margin operasi Adagene Corp ADAG|IMA - Rentabilitas operasi|Tingkat bathi operasi STTK (Shattuck Labs)|EQ: Margin operasi|Connect Biopharma (CNTB) - Margin operasi|Rentabilitas operasi Immunic|Margin operasi atarabio.com|Margin operasi IFRX|Margin operasi X4 Pharma (XFOR)|Margin operasi ACET (adicetbio.com)|Margin operasi Celularity Inc. CELU|INMB - Rentabilitas operasi|Tingkat bathi operasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Margin dodolan operasi|Margin dodolan operasi SAB Biotherapeutics Inc.|Margin dodolan operasi AKTX|Margin dodolan operasi enlivex.com (ENLV)|Rentabilitas operasi Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Tingkat bathi adhedhasar bathi operasi|Margin operasi EDSA (Edesa Biotech Corp)|Rentabilitas kegiatan operasi iBio (IBIO)|CARM - Rentabilitas operasi|XTL Biopharmaceuticals (XTLB) - Margin dodolan operasi|BOLT: Margin operasi|Margin dodolan operasi HCW Biologics Inc.|Rentabilitas operasi Aptevo|Rentabilitas dodolan miturut bathi operasi AIM (AIM ImmunoTech, Inc.)|Margin operasi ADTX|Rentabilitas kegiatan operasi GRI Bio Corp|Margin operasi XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Rentabilitas dodolan operasi|Revelation Biosciences Corp - Margin operasi|INDP (Indaptus Therapeutics, Inc.) - Rentabilitas dodolan miturut bathi operasi|SCNI: Margin operasi|CALI - Rentabilitas kegiatan operasi|AFMD (Affimed N.V.) - Margin operasi|Rentabilitas operasi ALLK|Margin dodolan operasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Rentabilitas dodolan operasi|Rentabilitas operasi iTeos ITOS|Ocean Bio - Rentabilitas operasi|TC BioPharm Ltd - Margin operasi|Rentabilitas dodolan operasi thirdharmonicbio.com